BMAL1-HIF2α heterodimers contribute to ccRCC [ChIP-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 15 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 15 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- BMAL1 and ARNT enable circadian HIF2α responses in clear cell renal cell carcinomaNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE269334_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1121238 and SRA study SRP512419. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 6 replicated groups read from 15 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8313249 786O, shControl, IP IgG (negative control) biol rep 1 786O, shControl, IP IgG…
- GSM8313250 786O, shControl, IP IgG (negative control) biol rep 2 786O, shControl, IP IgG…
- GSM8313251 786O, shControl, IP BMAL1, biol rep 1 786O, shControl, IP BMA…
- GSM8313252 786O, shControl, IP BMAL1, biol rep 2 786O, shControl, IP BMA…
- GSM8313253 786O, shControl, IP BMAL1, biol rep 3 786O, shControl, IP BMA…
- GSM8313254 786O, shControl, IP HIF2a, biol rep 1 786O, shControl, IP HIF…
- GSM8313255 786O, shControl, IP HIF2a, biol rep 2 786O, shControl, IP HIF…
- GSM8313256 786O, shControl, IP HIF2a, biol rep 3 786O, shControl, IP HIF…
- GSM8313257 786O, shBMAL1, IP IgG (negative control) biol rep 1 786O, shBMAL1, IP IgG (…
- GSM8313258 786O, shBMAL1, IP IgG (negative control) biol rep 2 786O, shBMAL1, IP IgG (…
- GSM8313259 786O, shBMAL1, IP BMAL1, biol rep 1 786O, shBMAL1, IP BMAL1…
- GSM8313260 786O, shBMAL1, IP BMAL1, biol rep 2 786O, shBMAL1, IP BMAL1…
- GSM8313261 786O, shBMAL1, IP HIF2a, biol rep 1 786O, shBMAL1, IP HIF2a…
- GSM8313262 786O, shBMAL1, IP HIF2a, biol rep 2 786O, shBMAL1, IP HIF2a…
- GSM8313263 786O, shBMAL1, IP HIF2a, biol rep 3 786O, shBMAL1, IP HIF2a…
- GSE280574 mChIP-seq for high-throughput epigenomic profiling reveals a decoupling of H2A.Z and H3K4me3 in cancer 576 samples shares chip-seq
- GSE271752 Macromolecular interactions dictate Polycomb-mediated epigenetic repression [ChIP-seq] 194 samples shares chip-seq
- GSE277608 Characterization of induced cohesin loop extrusion trajectories in living cells [ChIP-seq] 147 samples shares chip-seq
- GSE289805 Histone H4 lysine 20 tri-methylation safeguards breast cancer lineage fidelity and unfolded protein response [ChIP-seq/ATAC-seq] 126 samples shares chip-seq
- GSE297914 PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression [ChIP-seq] 112 samples shares chip-seq
- GSE239270 Investigate FOXA2, NKX2-1, CTCF and P300 cistrome and enhancer (H3K27ac and H3k4me1) reprogramming during NEPC transformation by ChIP-seq. 104 samples shares chip-seq
- GSE287042 Epigenetic landscape of synthetic human centromeres: Euchromatic modifications coexist interdependently at CENP-A dense regions and prevent intrusion of other modifications [ChIP-seq] 102 samples shares chip-seq
- GSE304612 Inhibition of p300/CREBBP catalytic activity drives context-dependent transcriptional activation in AML. [ChIP-seq] 95 samples shares chip-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.